The integration of virtual and in-person care, and expansion of mental health services is among the top health and well-being trends for next year.
Virtual care that integrates with in-person offerings and the continued expansion of mental health and well-being services are among six health and well-being trends that construct a “collective urgency” for employers and their workforces for 2022, according to a release by Business Group on Health.
The other trends identified by the Business Group are ongoing attention to health equity, quality and value; a reimagining of workforce well-being to support emerging needs; and a heightened focus on health policy.
All trends result of recent findings from the Business Group’s 2022 Large Employers’ Health Care Strategy and Plan Design Survey.
Released in August, the survey showed top concerns including health equity, the pandemic’s long-term impact, expanding access to mental healthcare, monitoring trends in healthcare delivery and preparing for an uptick in healthcare spending. The 136 large employers who took part in the Business Group survey in June 2021 represent diverse sectors of industry and provide health insurance for more than 8 million people.
“Each of these trends is critically important yet together underscore a collective urgency that requires prioritization,” said Ellen Kelsay, president and CEO of Business Group on Health. “To be sure, while COVID-19 still has an impact on almost every aspect of health and well-being, the upcoming year will be marked by large employers’ ongoing commitment to these critical areas.”
The six trends are:
Medicaid Cuts Remain Center Stage as Experts Address Industry Challenges
March 28th 2025In a recent conversation with Jennifer McGuigan Babcock, senior vice president for Medicaid policy at the Association for Community Affiliated Plans (ACAP), and Gabe Scott, a partner at K&L Gates Health Care Group, the two discussed efforts to protect Medicaid’s role in the healthcare system and the consequences of the budget cuts announced in February.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Approves Two More Denosumab Biosimilars, Conexxence and Bomyntra
March 27th 2025The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, as a result of a global settlement with Amgen, according to a company news release.
Read More
FDA Approves First Drug for Excess Hunger in Prader-Willi Syndrome
March 27th 2025Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi syndrome. The price is based on a patient’s weight, and the average patient in the clinical trials would have had an average annual cost of $466,200 for the first year.
Read More